보로노이

310210KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

131,900KRWMarket close of 10/20 (Tue)

Up +0.15%+200KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)136,900KRWUp +3.79%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
128,300
High
136,300
Low
125,400
Day range
Day range low 125,400 high 136,300, open 128,300, close 131,900, previous close 131,700
Volume
6×10K shares
8.1B KRW 0.72× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 100,800 to 363,500 won, 12% up from the low

12% of the way up from the lowest close in 1 year (252 sessions) · -63.7% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-81.0B KRWOperating income over the last four quarters -81.0B KRW (loss)Operating income, 8 quarters
  • Daily moveusual range+0.15%+0.15%, 0.0× the usual (20-session average ±5.81%)
    That day +0.15% · usual ±5.81% · large-move threshold ±11.6%
  • Trading valueusual range0.7×8.1B KRW, 0.7× the 20-session average
    0.72× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional-700.00 million KRWusual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -9.6%Down -3.35%51.1B KRW
올릭스Close over the last 20 sessions -12.2%Down -4.03%19.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
리가켐바이오Close over the last 20 sessions -15.4%Down -1.41%12.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 26 days
  • Next data 10/22 (Thu) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.